Casdin Capital’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.3M | Hold |
76,075,636
| – | – | 8.31% | 4 |
|
|
2025
Q1 | $82.2M | Buy |
76,075,636
+4,820,959
| +7% | +$5.21M | 6.71% | 4 |
|
|
2024
Q4 | $125M | Hold |
71,254,677
| – | – | 8.3% | 5 |
|
|
2024
Q3 | $138M | Buy |
71,254,677
+7,295,000
| +11% | +$14.1M | 9.17% | 4 |
|
|
2024
Q2 | $113M | Buy |
63,959,677
+2,052,072
| +3% | +$3.63M | 8.64% | 4 |
|
|
2024
Q1 | $168M | Buy |
61,907,605
+60,707,605
| +5,059% | +$165M | 12.47% | 2 |
|
|
2023
Q4 | $2.65M | Hold |
1,200,000
| – | – | 0.26% | 32 |
|
|
2023
Q3 | $3.48M | Hold |
1,200,000
| – | – | 0.39% | 29 |
|
|
2023
Q2 | $2.32M | Buy |
+1,200,000
| New | +$2.32M | 0.2% | 34 |
|